The Defense Advanced Research Projects Agency awarded a $299,978 definitive contract to Biosqueeze Inc. on June 3, 2025, for the Embedded Entrepreneur Initiative under a firm fixed-price arrangement.
The originating solicitation was a Commercial Solutions Opening posted May 1, 2024, through which DARPA seeks proposals to transition innovative commercial solutions from its R&D programs into capabilities that fulfill requirements, close capability gaps, or provide new technological advancements. DARPA evaluates proposals on technical merit and risk, importance to DARPA programs, offeror qualifications and capabilities, and proposed price. No set-aside was used.
Place of performance is Arlington, VA. The contract's ultimate completion date is August 2, 2026.
Biosqueeze Inc. is a small business specializing in biotechnology solutions for construction and materials engineering, with prior Phase II SBIR awards from the Air Force Research Laboratory focused on biomineralization technologies for expeditionary airfield construction.